Abstract
The NS1 protein of flaviviruses is taking center stage. Recent work has made it an attractive target for development of vaccines and immunotherapeutics. Cavazzoni and colleagues (2021. J. Exp. Med. https://doi.org/10.1084/jem.20210580) now reveal a dark side to NS1, linking it to the development of self-reactive antibodies.
Cite
CITATION STYLE
APA
Robbiani, D. F., & Růžek, D. (2021). A dark side to NS1 antibodies? Journal of Experimental Medicine, 218(9). https://doi.org/10.1084/jem.20211348
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free